SAN ANTONIO -- (BUSINESS WIRE) -- Today, BioMed SA, the non-profit corporation focused on growing and promoting San Antonio’s thriving healthcare and bioscience sector, will award its eighth annual Julio Palmaz Award for Innovation in Healthcare and the Biosciences to Robert S. Langer, Sc.D., the David H. Koch Institute Professor at the Massachusetts Institute of Technology, where he is one of 11 Institute Professors (the highest honor that can be awarded to a faculty member) and runs one of the largest research labs. The award, named after Palmaz® Stent inventor Julio Palmaz, M.D., honors individuals who have made significant contributions to advance the healthcare and bioscience fields. Langer will accept the award at BioMed SA’s annual Palmaz Award dinner to be held in San Antonio on Wednesday, September 18, 2013 at The Vistas at Valero.
Robert S. Langer, world-renowned engineer, medical inventor, and entrepreneur to receive the prestigious BioMed SA 2013 Julio Palmaz Award for Innovation in Healthcare and the Biosciences (Photo: Business Wire)
Previous recipients of the Palmaz Award include Larry Miller, MD, pioneering inventor, physician, and entrepreneur, founder & chief medical officer of Vidacare Corporation (2012); Leroy Hood, MD, Ph.D, president and co-founder, Institute for Systems Biology, Seattle, Washington (2011); C. Mauli Agrawal, dean of engineering at The University of Texas at San Antonio (2010); internationally acclaimed inventor Dean Kamen of DEKA Research & Development Corp. in New Hampshire (2009); Karen Davis, Ph.D, president of The Commonwealth Fund in New York (2007); and San Antonio pediatric surgeons Drs. Robert Campbell, Melvin Smith (deceased), and Kaye Wilkins from The University of Texas Health Science Center San Antonio and CHRISTUS Santa Rosa Children’s Hospital (2008).
“Dr. Langer’s stature as a world-famous engineer, medical inventor, and entrepreneur makes him a standout choice for this year’s award,” said Dr. Bruce Leslie, 2013 Palmaz Committee Chair and chancellor of the Alamo Colleges.
“Dr. Langer has made a profound impact upon the world of medicine,” noted Kenneth P. Trevett, BioMed SA’s Chairman.
"I'm thrilled to receive the Palmaz Award,” said Langer. “Dr. Palmaz and I were inducted into the National Inventors Hall of Fame together in 2006, and I was incredibly impressed with what Julio has done. I'm honored to receive a prize in his name."
About Dr. Langer
Dr. Langer has written more than 1,200 articles and is the most cited engineer in history. He also has more than 815 issued and pending patents worldwide. His patents have been licensed or sublicensed to more than 250 pharmaceutical, chemical, biotechnology and medical device companies. He also has founded or co-founded numerous health-related companies, which have commercialized products to treat cancer, heart disease, and many other conditions. He served as a member of the U.S. Food and Drug Administration’s SCIENCE Board, the FDA’s highest advisory board, from 1995-2002 and as its Chairman from 1999-2002.
Dr. Langer has received more than 220 major awards, including both the 2006 U.S. National Medal of Science and the 2011 U.S. National Medal of Technology and Innovation, the 2002 Charles Stark Draper Prize (considered the equivalent of the Nobel Prize for engineers), the 2008 Millennium Prize (the world’s largest technology prize), the 2012 Priestley Medal (highest award of the American Chemical Society), and the 2013 Wolf Prize in Chemistry. In 1998, he received the Lemelson-MIT prize, the world’s largest prize for invention for being “one of history’s most prolific inventors in medicine.”
He is the only engineer to receive the Gairdner Foundation International Award; 80 recipients of this award have subsequently received a Nobel Prize.
Among his numerous other honors are the Dickson Prize for Science (2002), Heinz Award for Technology, Economy and Employment (2003), the Harvey Prize (2003), the John Fritz Award (2003) (given previously to inventors such as Thomas Edison and Orville Wright), the General Motors Kettering Prize for Cancer Research (2004), the Dan David Prize in Materials Science (2005), the Albany Medical Center Prize in Medicine and Biomedical Research (2005), the largest prize in the U.S. for medical research, induction into the National Inventors Hall of Fame (2006), the Max Planck Research Award (2008), the Prince of Asturias Award for Technical and Scientific Research (2008), the Warren Alpert Foundation Prize (2011) and the Terumo International Prize (2012).
In 1989, Dr. Langer was elected to the Institute of Medicine, and in 1992 he was elected to both the National Academy of Engineering and the National Academy of Sciences. He is one of the very few people elected to all three U.S. National Academies and the youngest in history (at age 43) to ever receive this distinction.
Both Forbes Magazine (1999) and Bio World (1990) named Dr. Langer one of the 25 most important individuals in biotechnology in the world. Discover Magazine (2002) named him one of the 20 most important people in this area. Forbes Magazine (2002) selected him as one of 15 innovators worldwide who will reinvent our future. Time Magazine and CNN (2001) named Dr. Langer one of the 100 most important people in America and one of the nation’s 18 top people in science or medicine (America’s Best). Parade Magazine (2004) selected him as one of six “heroes whose research may save your life.”
Dr. Langer received his Bachelor’s Degree from Cornell University in 1970 and his Sc.D. from the Massachusetts Institute of Technology in 1974, both in Chemical Engineering. In addition, he has received honorary doctorates from numerous universities throughout the United States and the world.
ABOUT BIOMED SA
BioMed SA is a non-profit, membership-based organization, supported in part by the City of San Antonio. Its mission is to accelerate growth of San Antonio’s biomedical sector, create regional economic benefit, and contribute to the health of San Antonio and beyond by establishing San Antonio as a leader in healthcare and bioscience. The city’s healthcare and bioscience industry has added approximately 40,000 net new jobs over the past decade, significantly fueling San Antonio’s growth and employing more than one out of every six members of the city’s workforce. As America’s seventh largest city, San Antonio is a community that embraces science and medicine. Its vibrant health care and bioscience industry, a dominant force in the city’s economy with an annual economic impact exceeding $29 billion, combines unique assets and a diversity of resources with a collaborative spirit that is making a global impact on science and health. For more information, visit www.biomedsa.org.